Science Explorer Back to mapMap
Discussion
Research facility · Lexington · United States

Boston Collaborative Drug Surveillance Program

In research, Boston Collaborative Drug Surveillance Program stands highest in Medicine (#3,294 of 14,558 worldwide) and Health Sciences (#3,839 of 16,688 worldwide), over all time.

bcdsp.orgROR OpenAlex
World rank, all time
#19,629
of 34,923
Rank in United States
#4,071
of 7,310
Research works
207
▼ 18% vs 2018-21
Citations
15k
70.3 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
vs its own fields
1.30×
1.00× is exactly expected
Open access
32%
world 40%
International
31%
world 18%
Boston Collaborative Drug Surveillance Program

What is Boston Collaborative Drug Surveillance Program known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #3,294 of 14,558 25.6%147
Health SciencesDomain #3,839 of 16,688 26.2%153

Each strip is that field's whole ranked pool, with the notch where Boston Collaborative Drug Surveillance Program sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Boston Collaborative Drug Surveillance Program work in?

In all years, 74% of research at Boston Collaborative Drug Surveillance Program is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (8%), Pharmacology, Toxicology and Pharmaceutics (5%). It does 3.1× the world's share of Health Sciences.

Health Sciences: 153 fractional works · 74.3% of its workMedicine: 147 fractional works · 71.2% of its workPublic Health, Environmental and Occupational Health: 13 fractional works · 6.3% of its workPharmacology: 11 fractional works · 5.5% of its workEndocrinology, Diabetes and Metabolism: 9 fractional works · 4.4% of its workCardiology and Cardiovascular Medicine: 9 fractional works · 4.3% of its workPsychiatry and Mental health: 9 fractional works · 4.3% of its workPediatrics, Perinatology and Child Health: 8 fractional works · 4.0% of its workEpidemiology: 8 fractional works · 3.9% of its workSurgery: 8 fractional works · 3.8% of its workRheumatology: 8 fractional works · 3.6% of its workPulmonary and Respiratory Medicine: 7 fractional works · 3.5% of its workOncology: 7 fractional works · 3.2% of its workGeriatrics and Gerontology: 5 fractional works · 2.5% of its workPathology and Forensic Medicine: 4 fractional works · 2.0% of its workPhysiology: 4 fractional works · 2.0% of its workHematology: 4 fractional works · 1.9% of its workInternal Medicine: 3 fractional works · 1.7% of its workNeurology: 3 fractional works · 1.7% of its workDermatology: 3 fractional works · 1.4% of its workEmergency Medicine: 3 fractional works · 1.3% of its workOrthopedics and Sports Medicine: 2 fractional works · 1.2% of its workObstetrics and Gynecology: 2 fractional works · 1.1% of its workInfectious Diseases: 2 fractional works · 0.9% of its workNephrology: 2 fractional works · 0.9% of its workOphthalmology: 2 fractional works · 0.9% of its workHepatology: 2 fractional works · 0.9% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.6% of its workGastroenterology: 1 fractional works · 0.6% of its workFamily Practice: 1 fractional works · 0.6% of its workGenetics: 1 fractional works · 0.5% of its workUrology: 1 fractional works · 0.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.4% of its workImmunology and Allergy: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workHealth Professions: 5 fractional works · 2.5% of its workGeneral Health Professions: 2 fractional works · 1.1% of its workHealth Information Management: 2 fractional works · 1.1% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNursing: 1 fractional works · 0.5% of its workNutrition and Dietetics: 1 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 35 fractional works · 16.7% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 8.0% of its workMolecular Biology: 7 fractional works · 3.3% of its workGenetics: 5 fractional works · 2.5% of its workCancer Research: 3 fractional works · 1.7% of its workClinical Biochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 10 fractional works · 4.7% of its workPharmacology: 6 fractional works · 2.7% of its workToxicology: 4 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.0% of its workImmunology and Microbiology: 6 fractional works · 2.8% of its workImmunology: 4 fractional works · 2.0% of its workMicrobiology: 1 fractional works · 0.5% of its workApplied Microbiology and Biotechnology: 1 fractional works · 0.3% of its workNeuroscience: 2 fractional works · 1.0% of its workCognitive Neuroscience: 1 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workSocial Sciences: 11 fractional works · 5.5% of its workEconomics, Econometrics and Finance: 4 fractional works · 2.2% of its workEconomics and Econometrics: 4 fractional works · 2.2% of its workPsychology: 3 fractional works · 1.5% of its workClinical Psychology: 2 fractional works · 1.2% of its workSmaller subfields together: 1 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 0.8% of its workHealth: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.4% of its workDecision Sciences: 1 fractional works · 0.6% of its workStatistics, Probability and Uncertainty: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 1 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 3.5% of its workMathematics: 2 fractional works · 1.1% of its workStatistics and Probability: 2 fractional works · 1.1% of its workEnvironmental Science: 2 fractional works · 1.1% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.6% of its workSmaller subfields together: 1 fractional works · 0.4% of its workComputer Science: 2 fractional works · 0.8% of its workInformation Systems: 1 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.3% of its workEngineering: 1 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.2% of its workALL ITS WORKBostonCollaborative…206fractional works, all years
Life Sciences17%Physical Sciences3%Health Sciences74%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine14771.2%
    2. Health Professions52.5%
    3. Nursing10.5%
    4. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology178.0%
    2. Pharmacology, Toxicology and Pharmaceutics104.7%
    3. Immunology and Microbiology62.8%
    4. Neuroscience21.0%
    5. Agricultural and Biological Sciences00.2%
    1. Economics, Econometrics and Finance42.2%
    2. Psychology31.5%
    3. Social Sciences20.8%
    4. Decision Sciences10.6%
    5. Business, Management and Accounting10.3%
    6. Arts and Humanities00.2%
    1. Mathematics21.1%
    2. Environmental Science21.1%
    3. Computer Science20.8%
    4. Engineering10.4%
    5. Chemistry00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.40× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.11× its world share, 0 worksImmunology and Micro…Neuroscience: 0.32× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 21.96× its world share, 1 worksPharmacology, Toxico…Engineering: 0.01× its world share, 0 worksEngineeringMathematics: 0.20× its world share, 0 worksMathematicsHealth Professions: 1.33× its world share, 0 worksHealth ProfessionsMedicine: 3.68× its world share, 9 worksMedicineBusiness, Management and Accounting: 0.27× its world share, 0 worksBusiness, Management…Decision Sciences: 5.22× its world share, 1 worksDecision SciencesPsychology: 0.53× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 22.0×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics21.96×1 works
  2. Decision Sciences5.22×1 works
  3. Medicine3.68×9 works
  4. Biochemistry, Genetics and Molecular Biology1.40×1 works
  5. Health Professions1.33×0 works
  6. Immunology and Microbiology1.11×0 works
  7. Psychology0.53×0 works
  8. Neuroscience0.32×0 works
  9. Business, Management and Accounting0.27×0 works
  10. Mathematics0.20×0 works
  11. Agricultural and Biological Sciences0.14×0 works
  12. Social Sciences0.02×0 works
  13. Engineering0.01×0 works

Who are the top researchers at Boston Collaborative Drug Surveillance Program?

Ranked on the quality score, Hershel Jick, Susan Sara Jick and Jane Porter lead among researchers whose main affiliation is Boston Collaborative Drug Surveillance Program.

  1. 1 Hershel Jick United States · #143,328 worldwide 29k citations · 415 works
  2. 2 Susan Sara Jick United States · #177,859 worldwide 24k citations · 417 works
  3. 3 Jane Porter United States · #586,913 worldwide 5.3k citations · 55 works
  4. 4 Christoph Rudolf Meier United States · #587,446 worldwide 7.6k citations · 177 works
  5. 5 Laura E. Derby United States · #614,958 worldwide 3.7k citations · 37 works
  6. 6 Catherine Vasilakis United States · #962,259 worldwide 1.8k citations · 15 works
  7. 7 Catherine Vasilakis‐Scaramozza United States · #1,245,646 worldwide 1.7k citations · 31 works
  8. 8 Marian Wald Myers United States · #1,966,329 worldwide 1.4k citations · 20 works
  9. 9 Katrina Wilcox Hagberg United States · #1,973,816 worldwide 1.6k citations · 61 works
  10. 10 Alan D. Dean United States · #3,050,648 worldwide 1.2k citations · 28 works
All ranked researchers at Boston Collaborative Drug Surveillance Program

What are the most cited papers from Boston Collaborative Drug Surveillance Program?

The most cited paper from Boston Collaborative Drug Surveillance Program is "Statins and the risk of dementia" (Hershel Jick, GL Zornberg, Susan Sara Jick et al., 2000), with 1,770 citations. Next come "Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs" (978) and "Validation of information recorded on general practitioner based computerised data resource in the United Kingdom." (843).

Most cited papers
#PaperReleasedCitations
1 Statins and the risk of dementia Hershel Jick, GL Zornberg, Susan Sara Jick et al. · The Lancet Nov 2000 1,770
2 Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs La García Rodríguez, Hershel Jick · The Lancet Mar 1994 978
3 Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Hershel Jick, Susan Sara Jick, L E Derby · BMJ Open access 30 Mar 1991 843
4 Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Hershel Jick, Susan Sara Jick, Michael W. Myers et al. · The Lancet Open access Dec 1995 737
5 Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens Hershel Jick, Laura E. Derby, Marian Wald Myers et al. · The Lancet Open access Oct 1996 610
All 60 most cited papers, with filters and sorting

Which keywords describe research at Boston Collaborative Drug Surveillance Program?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Epidemiology, Treatment, Clinical Trials, Breast Cancer, Diagnosis, Cardiovascular Risk and Cardiovascular Disease.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation22▲ 4.5×32 topics
  2. Epidemiology22▲ 2.6×60 topics
  3. Treatment14▲ 5.3×25 topics
  4. Diagnosis11▲ 5.2×23 topics
  5. Oxidative Stress11▲ 2.9×20 topics
  6. Cardiovascular Disease11▲ 4.7×21 topics
  7. Risk Factors10▲ 4.5×15 topics
  8. Clinical Trials10▲ 7.5×9 topics
  9. Breast Cancer9▲ 16×8 topics
  10. Metabolic Syndrome9▲ 5.2×16 topics
  11. Cancer9▲ 3.1×11 topics
  12. Cardiovascular Risk9▲ 12×7 topics
  13. Adverse Drug Reactions8▲ 62×3 topics
  14. Genetics7▲ 4.6×13 topics
  15. Depression7▲ 4.6×8 topics
  16. Pregnancy7▲ 15×4 topics
  17. Clinical Practice Guidelines7▲ 5.9×9 topics
  18. Elderly6▲ 11×4 topics
  19. Biomarkers6▲ 4.5×7 topics
  20. Estrogen6▲ 36×2 topics
  21. Medication Adherence6▲ 47×2 topics
  22. Statins6▲ 34×2 topics
  23. Antithrombotic Therapy5▲ 25×2 topics
  24. Pathogenesis5▲ 4.7×12 topics
  25. Rheumatoid Arthritis5▲ 25×2 topics
  26. Cognitive Function5▲ 12×7 topics
  27. Inappropriate Medication Use5▲ 62×1 topic
  28. Polypharmacy5▲ 62×1 topic
  29. Autoantibodies5▲ 9.7×5 topics
  30. Bone Mineral Density5▲ 26×3 topics
  31. Hormone Therapy5▲ 21×3 topics
  32. Genetic Variants4▲ 10×6 topics
  33. Reproductive Health4▲ 51×3 topics
  34. Nuclear Receptors4▲ 12×5 topics
  35. Off-Label Drug Use4▲ 58×1 topic
  36. Pediatric Pharmacokinetics4▲ 58×1 topic
  37. Teratogenicity4▲ 32×2 topics
  38. Family Planning4▲ 39×2 topics
  39. Cardiovascular Disease Prevention4▲ 25×2 topics
  40. Colorectal Cancer4▲ 20×2 topics

Which research topics does Boston Collaborative Drug Surveillance Program publish most on?

By volume in 2022-now: Global Cancer Incidence and Screening, Venous Thromboembolism Diagnosis and Management, Pharmacovigilance and Adverse Drug Reactions and Medication Adherence and Compliance.

Global Cancer Incidence …0Global Cancer Incidence and Screening: 0 fractional worksVenous Thromboembolism D…0Venous Thromboembolism Diagnosis and Management: 0 fractional worksPharmacovigilance and Adverse Drug Reactions: 0 fractional worksMedication Adherence and Compliance: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksData Quality and Management: 0 fractional worksAntiplatelet Therapy and Cardiovascular Diseases: 0 fractional worksPancreatic and Hepatic O…0Pancreatic and Hepatic Oncology Research: 0 fractional worksNeurological Complications and Syndromes: 0 fractional worksMigraine and Headache Studies: 0 fractional works
OncologyInternal MedicineToxicologyFamily Practice4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Global Cancer Incidence and Screening Oncology 0 works
  2. 2 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  3. 3 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  4. 4 Medication Adherence and Compliance Family Practice 0 works
  5. 5 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  6. 6 Data Quality and Management Management Science and Operations Research 0 works
  7. 7 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works
  8. 8 Pancreatic and Hepatic Oncology Research Oncology 0 works
  9. 9 Neurological Complications and Syndromes Psychiatry and Mental health 0 works
  10. 10 Migraine and Headache Studies Psychiatry and Mental health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.2%not open67.8%

World: 40% of research is openly available.

with international co-authors31.3%domestic only68.7%

World: 18% is written across borders.

How has Boston Collaborative Drug Surveillance Program's research output changed?

Output in 2022-2025 was 18% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Boston Collaborative Drug Surveillance Program as a percentage of every work published that year, 0.000038% in 2024.

still counting0.0010%0.0020%0.0030%Boston Collaborative Drug Surveillance Program0.000049% in 202519801990200020102020

Fractional works of Boston Collaborative Drug Surveillance Program over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lexington

All research institutions in Lexington

Share Boston Collaborative Drug Surveillance Program's ranking

Boston Collaborative Drug Surveillance Program on Science Explorer

A card with Boston Collaborative Drug Surveillance Program's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Boston Collaborative Drug Surveillance Program. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.